Innovation and technology transfer are fundamental at 4CB, where projects are driven to translate leading cancer research into real-world clinical solutions. A clear example of this commitment is the group of active cancer spin-offs, which translate the latest biomedical discoveries into real patient care, helping improve diagnosis, personalized treatment, and the development of new solutions to meet the challenges in this field.
Innovation and technology transfer
Active spin-offs 2024
Athena Tech
AI-powered healthcare platform designed to streamline complex oncological patient data.
Gyala Therapeutics
Biomedical spin-off focused on the development of novel CAR-T therapies for hematological malignancies.
MiWEndo Solutions
Dedicated to innovation in colorectal cancer detection, it has developed a device that automates and improves early detection of this tumour during colonoscopy.
Reveal Genomics
Biomedical spin-off developing genomic tests, such as HER2DX®, to personalize treatment for breast cancer patients based on the integration of complex genetic and clinical data.
